Literature DB >> 23205353

Central Nervous System Cryptococcosis among a Cohort of HIV Infected Patients from a University Hospital of North India.

Chaitanya Nigam1, Rupam Gahlot, Vikas Kumar, Jaya Chakravarty, Ragini Tilak.   

Abstract

BACKGROUND: Cryptococcus neoformans is a ubiquitous encapsulated yeast that causes significant infections which range from asymptomatic pulmonary colonization to the life threatening meningoencephalitis, especially in immunocompromised individuals. Cryptococcal meningitis is one of the AIDS-defining illnesses. Recent data have indicated that, the incidence of the cryptococcal infection is high in developing countries like India. We conducted this study to find out the incidence of cryptococcosis in this area.
MATERIAL AND METHODS: The Cerebrospinal Fluid (CSF) specimens were collected from known HIV positive cases that had a clinical diagnosis of meningitis and they were processed by standard microbiological procedures. The cryptococcal isolates were identified by microscopy, their cultural characteristics, sugar assimilation and by the hydrolysis of urea.
RESULTS: The incidence of cryptococcal meningitis was 12.9%. All the strains were susceptible to amphotericin B, fluconazole, itraconazole and voriconazole.
CONCLUSION: The cryptococcal infection should be suspected in all cases of meningitis, especially among HIV infected persons. An early diagnosis and treatment may alter the prognosis of these patients and hence, an examination of the CSF for cryptococcosis should be considered in all the HIV infected persons who have the symptoms of meningitis.

Entities:  

Keywords:  Cryptococcal meningitis; HIV; India ink; Latex agglutination

Year:  2012        PMID: 23205353      PMCID: PMC3471506          DOI: 10.7860/JCDR/2012/4158.2365

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

1.  Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa.

Authors:  A S Karstaedt; H H Crewe-Brown; F Dromer
Journal:  Med Mycol       Date:  2002-02       Impact factor: 4.076

Review 2.  HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Thomas S Harrison
Journal:  AIDS       Date:  2007-10-18       Impact factor: 4.177

3.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Authors:  P G Pappas; J R Perfect; G A Cloud; R A Larsen; G A Pankey; D J Lancaster; H Henderson; C A Kauffman; D W Haas; M Saccente; R J Hamill; M S Holloway; R M Warren; W E Dismukes
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

4.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  [Neurologic manifestations associated with HIV infections at the Bobo-Dioulasso Hospital Center (Burkina Faso)].

Authors:  A Millogo; G A Ki-Zerbo; A B Sawadogo; I Ouedraogo; A Yameogo; M M Tamini; M Peghini
Journal:  Bull Soc Pathol Exot       Date:  1999-02

6.  Humoral defense mechanisms in cryptococcosis: substances in normal human serum, saliva, and cerebrospinal fluid affecting the growth of Cryptococcus neoformans.

Authors:  H J Igel; R P Bolande
Journal:  J Infect Dis       Date:  1966-02       Impact factor: 5.226

7.  Risk factors for cryptococcal meningitis in HIV-infected patients.

Authors:  K A Oursler; R D Moore; R E Chaisson
Journal:  AIDS Res Hum Retroviruses       Date:  1999-05-01       Impact factor: 2.205

8.  Clinical manifestations of AIDS with cryptococcal meningitis.

Authors:  W Wang; A R Carm
Journal:  Chin Med J (Engl)       Date:  2001-08       Impact factor: 2.628

Review 9.  The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.

Authors:  S M Levitz
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

10.  Prevalence and clinical presentation of Cryptococcal meningitis among HIV seropositive patients.

Authors:  Vasant Baradkar; M Mathur; A De; S Kumar; M Rathi
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-01
View more
  4 in total

1.  Cryptococcal meningitis in patients with autoimmune hemolytic anemia.

Authors:  YaLi Yang; Junjun Sang; Weihua Pan; Lin Du; Wanqing Liao; Jianghan Chen; Yuanjie Zhu
Journal:  Mycopathologia       Date:  2014-06-21       Impact factor: 2.574

2.  A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset.

Authors:  H Zheng; Q Chen; Z Xie; D Wang; M Li; X Zhang; Y Man; J Lao; N Chen; L Zhou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-20       Impact factor: 3.267

3.  Clinical characteristics, Cryptococcus neoformans genotypes, antifungal susceptibility, and outcomes in human immunodeficiency virus-positive patients in Beijing, China.

Authors:  Xinmin Xu; Pengcheng Du; Huizhu Wang; Xiaoling Yang; Tingting Liu; Yuanyuan Zhang; Yajie Wang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  A retrospective study of contributing factors for prognosis and survival length of cryptococcal meningoencephalitis in Southern part of China (1998-2013).

Authors:  Hui Zheng; Mingyue Li; Yingting Luo; Dongmei Wang; Jialing Yang; Qiong Chen; Junying Lao; Ningfen Chen; Man Yang; Qun Wang
Journal:  BMC Infect Dis       Date:  2015-02-19       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.